Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeReference
- Nephropathy in patients with type 2 diabetes mellitus.N. Engl. J. Med. 1999; 341: 1127-1133
- The United States Renal Data System's 1990 Annual Data Report: an introduction.Am. J. Kidney Dis. (Suppl 2). 1990; 16: 1-106
- Incidence of end-stage renal disease in type 2 diabetes mellitus in Pima Indians.Diabetologia. 1988; 31: 730-736
- Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials.Am. J. Kidney Dis. 2000; 35: 695-707
- Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.Ann. Intern. Med. 2001; 135: 73-87
- Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.N. Engl. J. Med. 2004; 351: 1952-1961
- The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis.Ann. Intern. Med. 1996; 124: 627-632
- The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.J. Diabetes Complications. 1994; 8: 13-17
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.Diabetes Res. Clin. Pract. 1995; 28: 103-117
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification: Kidney Disease Outcome Quality Initiative. Am. J. Kidney Dis. 39 (2002) S1–S266.
- Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.JAMA. 2003; 289: 3273-3277
- Prevalence of kidney damage in Australian adults: the AusDiab kidney study.J. Am. Soc. Nephrol. 2003; 14: S131-S138
- A population survey on the prevalence of diabetes in Kin-Hu, Kinmen.Diabetes Care. 1994; 17: 1055-1058
World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus, World Health Organization, Geneva, 1999.
- Use of single voided urine samples to estimate quantitative proteinuria.N. Engl. J. Med. 1983; 309: 1543-1546
- Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 h urine protein excretion rate, glomerular filtration rate, and end-stage renal failure in chronic renal disease in patients without diabetes.BMJ. 1998; 316: 504-509
- A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group.Ann. Intern. Med. 1999; 130: 461-470
- Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment.Kidney Int. 2000; 55: 1878-1884
- Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.Kidney Int. 2002; 61: 2165-2175
- Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension.Diabetes Res. 1993; 22: 115-121
- Predicting diabetic nephropathy in insulin-dependent patients.N. Engl. J. Med. 1984; 311: 89-93
- Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus.Lancet. 1982; 1: 1430-1432
- The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control.JAMA. 1990; 263: 1954-1960
- Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.Ann. Intern. Med. 2001; 134: 629-636
- Lipids—what is the evidence for their role in progressive renal disease?.Nephrol. Dial. Transplant. 1995; 10: 14-16
- Combined renal effects of overweight and hypertension.Hypertension. 1995; 26: 610-615
- A role for uric acid in the progression of renal disease.J. Am. Soc. Nephrol. 2002; 13: 2888-2897
- Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function?.J. Nephrol. 2004; 17: 666-672
- Number needed to screen: development of a statistic for disease screening.BMJ. 1998; 317: 307-312
- Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988–1994).Arch. Intern. Med. 2001; 161: 1207-1216